Mini Review
Published on 29 Sep 2014
Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00256
- 12,408 views
- 20 citations
79 articles related to "Non Squamous"
Articles
Mini Review
Published on 25 Nov 2014
Promising Targets and Current Clinical Trials in Metastatic Non-Squamous NSCLC
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00329
- 10,035 views
- 35 citations
Mini Review
Published on 04 May 2016
Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2016.00112
- 10,647 views
- 30 citations
Review
Published on 09 Jul 2021
A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expression
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.676732
- 22,539 views
- 24 citations
Original Research
Published on 14 Feb 2023
Cost-effectiveness of camrelizumab plus chemotherapy vs. chemotherapy in the first-line treatment of non-squamous NSCLC: Evidence from China
in Pulmonary Medicine
Frontiers in Medicine
doi 10.3389/fmed.2023.1122731
- 2,790 views
- 2 citations
Original Research
Published on 10 Jan 2022
Cost-Effectiveness of Pembrolizumab Plus Chemotherapy Versus Pembrolizumab Monotherapy in Metastatic Non-Squamous and Squamous NSCLC Patients With PD-L1 Expression ≥ 50%
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2021.803626
- 6,370 views
- 7 citations
Original Research
Published on 14 Jan 2026
Comparative cost-effectiveness of sintilimab, toripalimab, and camrelizumab in first-line therapy for advanced non-squamous non-small cell lung cancer
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1754642
- 822 views
Mini Review
Published on 29 Sep 2017
Targeting Novel but Less Common Driver Mutations and Chromosomal Translocations in Advanced Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2017.00222
- 4,952 views
- 6 citations
Case Report
Published on 11 Aug 2022
Case report: Salvage capmatinib therapy in KIF5B-MET fusion-positive lung adenocarcinoma with resistance to telisotuzumab vedotin
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.919123
- 3,792 views
- 4 citations
Brief Research Report
Published on 27 Oct 2025
Impact of prior immunotherapy on paclitaxel/bevacizumab in advanced non-squamous non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1675386
- 1,527 views
Case Report
Published on 02 Feb 2023
Chemo-immunotherapy for metastatic non-squamous NSCLC in a patient with HIV infection: A case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1053497
- 2,225 views
Original Research
Published on 13 Apr 2021
MGA Mutation as a Novel Biomarker for Immune Checkpoint Therapies in Non-Squamous Non-Small Cell Lung Cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2021.625593
- 6,486 views
- 14 citations
Mini Review
Published on 20 Mar 2017
Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2017.00038
- 20,886 views
- 22 citations
Original Research
Published on 06 Nov 2024
Association of artificial intelligence-based immunoscore with the efficacy of chemoimmunotherapy in patients with advanced non-squamous non-small cell lung cancer: a multicentre retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1485703
- 4,720 views
- 3 citations
Original Research
Published on 29 Sep 2021
Direct Comparison Between the Addition of Pembrolizumab or Bevacizumab for Chemotherapy-Based First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer Lacking Driver Mutations
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.752545
- 5,852 views
- 6 citations
Case Report
Published on 03 Aug 2023
Hepatic cavernous hemangioma developed in non-small cell lung cancer patients after receiving Camrelizumab treatment: two case reports
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1221309
- 3,469 views
- 3 citations